Literature DB >> 24899440

Serum virus neutralization assay for detection and quantitation of serum-neutralizing antibodies to influenza A virus in swine.

Phillip C Gauger1, Amy L Vincent.   

Abstract

The serum virus neutralization (SVN) assay is a serological test to detect the presence and magnitude of functional systemic antibodies that prevent infectivity of a virus. The SVN assay is a highly sensitive and specific test that may be applied to influenza A viruses in swine to measure the titer of neutralizing antibodies post-infection or after vaccination. Conventional SVN methods performed in vitro are based on inhibition of virus infectivity in cell culture in the presence of neutralizing antibodies. Titer determination may be based on the presence or the absence of cytopathic effect or the evidence of viral infection using an immunoreactive technique. The SVN assay is relatively inexpensive using standard laboratory equipment although it requires cell culture, more time and labor, and technical skill to conduct the assay compared to other serological methods. The SVN test is useful to evaluate the level of serological cross-reactivity between vaccine antisera and variant influenza viruses that may correlate with cross-protection in the host.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24899440     DOI: 10.1007/978-1-4939-0758-8_26

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  24 in total

1.  Novel Reassortant Human-Like H3N2 and H3N1 Influenza A Viruses Detected in Pigs Are Virulent and Antigenically Distinct from Swine Viruses Endemic to the United States.

Authors:  Daniela S Rajão; Phillip C Gauger; Tavis K Anderson; Nicola S Lewis; Eugenio J Abente; Mary Lea Killian; Daniel R Perez; Troy C Sutton; Jianqiang Zhang; Amy L Vincent
Journal:  J Virol       Date:  2015-08-26       Impact factor: 5.103

2.  Reassortment between Swine H3N2 and 2009 Pandemic H1N1 in the United States Resulted in Influenza A Viruses with Diverse Genetic Constellations with Variable Virulence in Pigs.

Authors:  Daniela S Rajão; Rasna R Walia; Brian Campbell; Phillip C Gauger; Alicia Janas-Martindale; Mary Lea Killian; Amy L Vincent
Journal:  J Virol       Date:  2017-01-31       Impact factor: 5.103

3.  Novel recombinant DNA vaccine candidates for human respiratory syncytial virus: Preclinical evaluation of immunogenicity and protection efficiency.

Authors:  Mohamed A Farrag; Haitham M Amer; Peter Öhlschläger; Maaweya E Hamad; Fahad N Almajhdi
Journal:  Hum Vaccin Immunother       Date:  2017-03-08       Impact factor: 3.452

4.  Heterologous challenge in the presence of maternally-derived antibodies results in vaccine-associated enhanced respiratory disease in weaned piglets.

Authors:  Daniela S Rajao; Matthew R Sandbulte; Phillip C Gauger; Pravina Kitikoon; Ratree Platt; James A Roth; Daniel R Perez; Crystal L Loving; Amy L Vincent
Journal:  Virology       Date:  2016-02-11       Impact factor: 3.616

5.  Evaluation of two multiplex RT-PCR assays for detection and subtype differentiation of Brazilian swine influenza viruses.

Authors:  Vanessa Haach; Danielle Gava; Maurício Egídio Cantão; Rejane Schaefer
Journal:  Braz J Microbiol       Date:  2020-03-03       Impact factor: 2.476

6.  Alphavirus-vectored hemagglutinin subunit vaccine provides partial protection against heterologous challenge in pigs.

Authors:  Eugenio J Abente; Daniela S Rajao; Phillip C Gauger; Amy L Vincent
Journal:  Vaccine       Date:  2019-02-02       Impact factor: 3.641

7.  Comparison of Adjuvanted-Whole Inactivated Virus and Live-Attenuated Virus Vaccines against Challenge with Contemporary, Antigenically Distinct H3N2 Influenza A Viruses.

Authors:  Eugenio J Abente; Daniela S Rajao; Jefferson Santos; Bryan S Kaplan; Tracy L Nicholson; Susan L Brockmeier; Phillip C Gauger; Daniel R Perez; Amy L Vincent
Journal:  J Virol       Date:  2018-10-29       Impact factor: 5.103

8.  Hippo Signaling Pathway Activation during SARS-CoV-2 Infection Contributes to Host Antiviral Response.

Authors:  Gustavo Garcia; Yijie Wang; Joseph Ignatius Irudayam; Arjit Vijey Jeyachandran; Sebastian Castillo Cario; Chandani Sen; Shen Li; Yunfeng Li; Ashok Kumar; Karin Nielsen-Saines; Samuel W French; Priya S Shah; Kouki Morizono; Brigitte Gomperts; Arjun Deb; Arunachalam Ramaiah; Vaithilingaraja Arumugaswami
Journal:  bioRxiv       Date:  2022-04-08

Review 9.  Challenges in Laboratory Diagnosis of the Novel Coronavirus SARS-CoV-2.

Authors:  Nadin Younes; Duaa W Al-Sadeq; Hadeel Al-Jighefee; Salma Younes; Ola Al-Jamal; Hanin I Daas; Hadi M Yassine; Gheyath K Nasrallah
Journal:  Viruses       Date:  2020-05-26       Impact factor: 5.048

Review 10.  Optimal Use of Vaccines for Control of Influenza A Virus in Swine.

Authors:  Matthew R Sandbulte; Anna R Spickler; Pamela K Zaabel; James A Roth
Journal:  Vaccines (Basel)       Date:  2015-01-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.